⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SGMT News
Sagimet Biosciences Inc. Series A Common Stock
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
globenewswire.com
SGMT
Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026
globenewswire.com
SGMT
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
SGMT
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes
globenewswire.com
SGMT